Alumis (ALMS) IPO deck
Alumis is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to transform the lives of patients with immune-mediated diseases.
Alumis is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to transform the lives of patients with immune-mediated diseases.
%20IPO%20deck){kind=link}